Your browser doesn't support javascript.
loading
DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase II study.
Miyazaki, Kana; Asano, Naoko; Yamada, Tomomi; Miyawaki, Kohta; Sakai, Rika; Igarashi, Tadahiko; Nishikori, Momoko; Ohata, Kinya; Sunami, Kazutaka; Yoshida, Isao; Yamamoto, Go; Takahashi, Naoki; Okamoto, Masataka; Yano, Hiroki; Nishimura, Yuki; Tamaru, Satoshi; Nishikawa, Masakatsu; Izutsu, Koji; Kinoshita, Tomohiro; Suzumiya, Junji; Ohshima, Koichi; Kato, Koji; Katayama, Naoyuki; Yamaguchi, Motoko.
Affiliation
  • Miyazaki K; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Mie. kmiyazaki@clin.medic.mie-u.ac.jp.
  • Asano N; Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka.
  • Yamada T; Department of Medical Innovation, Osaka University Hospital, Suita.
  • Miyawaki K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka.
  • Sakai R; Department of Medical Oncology, Kanagawa Cancer Center, Yokohama.
  • Igarashi T; Hematology/Oncology Division, Gunma Cancer Center, Ohta.
  • Nishikori M; Department of Hematology and Oncology, Kyoto University Graduate School of Medicine, Kyoto.
  • Ohata K; Department of Hematology, Kanazawa University, Kanazawa.
  • Sunami K; Department of Hematology, National Hospital Organization Okayama Medical Center, Okayama.
  • Yoshida I; Department of Hematologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama.
  • Yamamoto G; Department of Hematology, Toranomon Hospital, Tokyo.
  • Takahashi N; Department of Hematology and Oncology, International Medical Center, Saitama Medical University, Hidaka.
  • Okamoto M; Department of Hematology, Fujita Health University School of Medicine, Toyoake.
  • Yano H; Department of Hematology, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi.
  • Nishimura Y; Clinical Research Support Center, Mie University Hospital, Tsu.
  • Tamaru S; Clinical Research Support Center, Mie University Hospital, Tsu.
  • Nishikawa M; Clinical Research Support Center, Mie University Hospital, Tsu.
  • Izutsu K; Department of Hematology, Toranomon Hospital, Tokyo; Department of Hematology, National Cancer Center Hospital, Tokyo.
  • Kinoshita T; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya.
  • Suzumiya J; Department of Oncology and Hematology, Shimane University Hospital, Izumo.
  • Ohshima K; Department of Pathology, Kurume University School of Medicine, Kurume, Japan.
  • Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka.
  • Katayama N; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Mie.
  • Yamaguchi M; Department of Hematology and Oncology, Mie University Graduate School of Medicine, Mie.
Haematologica ; 105(9): 2308-2315, 2020 09 01.
Article in En | MEDLINE | ID: mdl-33054055
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Lymphoma, Large B-Cell, Diffuse Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Haematologica Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Lymphoma, Large B-Cell, Diffuse Type of study: Diagnostic_studies / Guideline / Prognostic_studies Limits: Humans Language: En Journal: Haematologica Year: 2020 Type: Article